These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4167033)

  • 1. The adamantyl group in medicinal agents. 3. Nucleoside 5'-adamantoates. The adamantoyl function as a protecting group.
    Gerzon K; Kau D
    J Med Chem; 1967 Mar; 10(2):189-99. PubMed ID: 4167033
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of potential antineoplastic agents. XIV. Some 2-substituted 2,3-dihydro-1h-perimidines.
    Wasulko W; Noble AC; Popp FD
    J Med Chem; 1966 Jul; 9(4):599-601. PubMed ID: 4165378
    [No Abstract]   [Full Text] [Related]  

  • 3. 1,3,2-diazaphosphorine 2-oxides. 3. Preparation and biological evaluation of some 1,3-bis(aralkyl)-2-halo-1,3,2-diazaphosphorine 2-oxides and related compounds.
    Billman JH; Meisenheimer JL; May RF
    J Med Chem; 1966 Sep; 9(5):772-4. PubMed ID: 4291025
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
    Hartmann HR; Bollag W
    Med Oncol Tumor Pharmacother; 1986; 3(2):111-8. PubMed ID: 2943952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated pyrimidines. 28. The synthesis of 5-trifluoromethyl-6-azauracil and 5-trifluoromethyl-6-aza-2'-deoxyuridine.
    Dipple A; Heidelberger C
    J Med Chem; 1966 Sep; 9(5):715-8. PubMed ID: 5338855
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
    Prince HN; Grunberg E; Buck M; Cleeland R
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347
    [No Abstract]   [Full Text] [Related]  

  • 7. The carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. 3. Primary correlation.
    French FA; Blanz EJ
    J Med Chem; 1966 Jul; 9(4):585-9. PubMed ID: 5968028
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyrimidines. XVI. 2,4,5-Triaminopyrimidines and related compounds.
    O'Brien DE; Noell CW; Robins RK; Cheng CC
    J Med Chem; 1966 Jan; 9(1):121-6. PubMed ID: 6006225
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of potential antineoplastic agents. XV. Some l,4-bisamides of 1,2,3,4-tetrahydroquinoxaline.
    Schuyler P; Popp FD; Noble AC; Alwani DW; Masters BR
    J Med Chem; 1966 Sep; 9(5):704-7. PubMed ID: 6007964
    [No Abstract]   [Full Text] [Related]  

  • 11. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleosides. XXIX. 1-beta-D-arabinofuranosyl-5-fluorocytosine and related arabino nucleosides.
    Fox JJ; Miller N; Wempen I
    J Med Chem; 1966 Jan; 9(1):101-5. PubMed ID: 5958936
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of periodate-oxidation products of carbohydrates and their derivatives.
    Dvonch W; Fletcher H; Gregory FJ; Healy EM; Warren GH; Alburn HE
    Cancer Res; 1966 Nov; 26(11):2386-9. PubMed ID: 4289174
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and cytotoxicity of 4-aminobutyrophenone hydrochlorides and their substituted pyrimidinylhydrazones.
    Cheng SS; Piantadosi C; Irvin JL
    J Med Chem; 1966 Nov; 9(6):945-9. PubMed ID: 4961672
    [No Abstract]   [Full Text] [Related]  

  • 15. Derivatives of fluorene. XXII. Nitrogen mustards. II.
    Fletcher TL; Wetzel WH; Namkung MJ
    J Med Chem; 1966 Jul; 9(4):593-8. PubMed ID: 5968030
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential carcinolytic agents. V. Enamine mustards.
    Papanastassiou ZB; Bruni RJ; White E
    J Med Chem; 1967 Jul; 10(4):701-6. PubMed ID: 6037064
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
    Nelson HG; Shelton FJ; Wetzel WH
    J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on chemotherapeutic agents. 3. A synthesis of 3-phenypurine derivatives.
    Kishikawa T; Yuki H
    Chem Pharm Bull (Tokyo); 1966 Dec; 14(12):1365-70. PubMed ID: 5977957
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of 5-bromouridine on the reproduction of vaccinia virus].
    Galegov GA; Bikbulatov RM; Linitskaia GL
    Biokhimiia; 1970; 35(3):470-6. PubMed ID: 5471001
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA.
    Suk D; Simpson CL; Mihich E
    Cancer Res; 1970 May; 30(5):1429-36. PubMed ID: 5426945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.